LeMaitre Vascular develops, manufactures, and markets medical devices for vascular surgery worldwide. The company offers various products including angioscope, embolectomy catheters, thrombectomy catheters, occlusion catheters, and perfusion catheters. They also provide biologic grafts, patches, carotid shunts, biosynthetic vascular grafts, and vascular grafts for bypass or replacement of diseased arteries. Additionally, they offer radiopaque tape to locate tributaries or lesions beneath the skin. Valvulotomes are used to cut or disrupt valves in the saphenous vein. Closure systems attach vessels with titanium clips instead of sutures. The company markets its products through a direct sales force and distributors.
Indicator | Value |
---|---|
PER | 42.1 |
EV/EBITDA | 30.2 |
Price/Free Cash Flow' | 49.9 |
ROIC | 8.4% |
Net Debt/EBITDA | 2.4 |